• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553660
Device Problems Use of Device Problem (1670); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fistula (1862); Hemorrhage/Bleeding (1888); Septic Shock (2068); Hematemesis (4478)
Event Date 03/01/2021
Event Type  Death  
Manufacturer Narrative
Date of event was approximated to (b)(6) 2021 as the event occurred before (b)(6) 2021 when the article was published.The complainant was unable to provide the suspect device lot number.Therefore, the manufacture and expiration dates are unknown.Literature source: patel, r.H., everett, b.T., akselrod, d., frasca, j.D., & gordon, s.R.(2021).Fatal aortoesophageal fistula complicating placement of a 20-mm lumen-apposing metal stent for refractory esophagojejunal anastomotic stricture.Acg case reports journal, 8(3).Doi:10.14309/crj.0000000000000548.(b)(4).The patient expired, the stent remains implanted and will not be returned for evaluation; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
Boston scientific became aware of an event involving a hot axios stent through the article "fatal aortoesophageal fistula complicating placement of a 20-mm lumen-apposing metal stent for refractory esophagojejunal anastomotic stricture" by dr.Rupal h.Patel, et al.It was reported to boston scientific corporation on april 05, 2021 that a hot axios stent was implanted to treat a benign refractory esophagojejunal anastomotic stricture in the esophagus during a procedure performed on an unknown date.It was reported that the plan was to leave the axios implanted for 12 weeks.During the procedure, the axios stent was successfully deployed.However, 6 weeks after the stent placement procedure the patient experienced hematemesis and hemodynamic instability.An upper endoscopy was performed and rapid arterial hemorrhage from the distal edge of the stent was noted.Computerized tomography angiogram and arteriogram were also performed and an aortoenteric fistula was noted, as well as, erosion of the distal flange into the aorta.The aortoenteric fistula was treated with an endovascular stent graft; however, the patient subsequently developed septic shock from escherichia coli bacteremia and passed away the next day.In the physician's assessment, there was a relationship between the patient's death and the axios stent.It is unknown if an autopsy was performed.The physician reported it might be best to avoid using the 20-mm lams for benign refractory esophageal strictures and instead use the smaller 15-mm lams.The physician suspects that the size of axios and the radial force exerted by the flange width may have resulted in the development of the aortoesophageal fistula.Note: it was reported that the axios stent was intended to be placed to treat a benign refractory esophagojejunal anastomotic stricture in the esophagus.However, per the hot axios stent and electrocautery- enhanced delivery system directions for use, the stent is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6 cm in size and walled-off necrosis >= 6 cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.The hot axios stent is not indicated to be implanted in the esophagus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key11745134
MDR Text Key247945179
Report Number3005099803-2021-01915
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729951179
UDI-Public08714729951179
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K163272
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM00553660
Device Catalogue Number5366
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/05/2021
Initial Date FDA Received04/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Other;
Patient Age66 YR
-
-